Combining robust urine biomarkers to assess chronic kidney disease progression.

EBioMedicine · 2023 · PMC10279781 · PMID 37285616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

on the borderline of significanceno p-value reported

Considering the biomarkers individually, we observed a significant and independent association with the risk of fast CKD progression for cystatin C, CCL2, fibronectin, GDF15, TGF-α, TIMP1, and VEGFA, and on the borderline of significance for EGF.

also in 23 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.